Abstract
Cytochrome P450 enzymes (CYPs) are heme-containing enzymes that catalyze hydroxylation with a variety of biological molecules. Despite their diverse activity and substrates, the structures of CYPs are limited to a tertiary structure that is similar across all the enzymes. It has been presumed that CYPs overcome substrate selectivity with highly flexible loops and divergent sequences around the substrate entrance region. Here, we report the newly identified CYP101D5 from Sphingomonas echinoides. CYP101D5 catalyzes the hydroxylation of β-ionone and flavonoids, including naringenin and apigenin, and causes the dehydrogenation of α-ionone. A structural investigation and comparison with other CYP101 families indicated that spatial constraints at the substrate-recognition site originate from the B/C loop. Furthermore, charge distribution at the substrate binding site may be important for substrate selectivity and the preference for CYP101D5.
Funder
National Research Foundation of Korea
Korea Institute of Marine Science & Technology Promotion
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference71 articles.
1. Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity;Solanki;Drug Metab. Dispos.,2018
2. Role of Human Cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16α-Hydroxylation of 17β-Estradiol;Badawi;Metabolism.,2001
3. Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors;Rendic;Drug Metab. Rev.,1997
4. Regioselective Hydroxylation of Steroid Hormones by Human Cytochromes P450;Niwa;Drug Metab. Rev.,2015
5. Species Differences between Mouse, Rat, Dog, Monkey and Human CYP-Mediated Drug Metabolism, Inhibition and Induction;Martignoni;Expert Opin. Drug Metab. Toxicol.,2006
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献